undamentalytics Newsletter

Tandem Diabetes Care Inc revenue

Tandem Diabetes Care Inc's revenue was $1.01bn in fiscal 2025, up 7.9% on the year before. Since fiscal 2012 ($2.5m) it has grown at a compound 58.8% a year. Over the last twelve months it was $1.04bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Tandem Diabetes Care Inc: revenue history, annual
Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2295073841081843624997038017489401,0151,041
Growth on the year before—+>999%+71.4%+46.5%+15.6%+27.7%+70.9%+97.0%+37.7%+40.9%+14.0%−6.7%+25.7%+7.9%—
Gross profit−161527244490194261376413368490546583
Gross margin−54.5%21.3%30.7%36.5%28.0%41.0%48.9%53.6%52.2%53.5%51.5%49.2%52.1%53.8%56.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Supplies and Other $551M 54.3% ▲ 15.7%
Pump $464M 45.7% ▲ 6.9%
Tandem Choice Program Recognized Deferred $0 0.0% ▼ 100.0%
Geography
Region Revenue Share YoY
United States $707M 69.7% ▲ 5.1%
Outside the US $308M 30.3% ▲ 15.1%

From Tandem Diabetes Care Inc's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Tandem Diabetes Care Inc $1.04bn 4.0% 9.6%
Inspire Medical Systems, Inc. $881m -0.2% 15.6%
Varex Imaging Corp $865m 5.3% -1.2%
Alphatec Holdings, Inc. $840m 15.3% 23.1%
Orthofix Medical Inc. $833m 3.0% 11.7%
Irhythm Holdings, Inc. $825m 25.6% 22.2%

Compare with peers

Head to head: INSP vs TNDMTNDM vs VREXATEC vs TNDM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Tandem Diabetes Care Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tandem Diabetes Care Inc.